Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography

Bayly, 1966, Stability and storage of compounds labeled with radioisotopes, J. Labelled Compd., 2, 1, 10.1002/jlcr.2590020102 Bogni, 2003, Stability of l-[S-methyl-11C]methionine molutions, J. Radioanal. Nucl. Chem., 256, 199, 10.1023/A:1023964712999 Bormans, 1995, Synthesis of N-tert-butyl-α-(4-[18F]fluorophenyl)-nitrone ([18F]FPBN) for in vivo detection of free radicals, J. Labelled Compd. Radiopharm., 36, 103, 10.1002/jlcr.2580360202 Cai, 2007, Radioligand development for PET imaging of β-amyloid (Ab)-current status, Curr. Med. Chem., 14, 19, 10.2174/092986707779313471 Chen, J., Linder, K.E., Marinelli, E.R., Metcalfe, E., Nunn, A., Swenson, R.E., Tweedle, M., 2005. Stable radiopharmaceutical compositions and methods for their preparations. PCT Int. Appl. WO2005009393, p. 117. Cohen, 2007, The application of positron-emitting molecular imaging tracers in Alzheimer's disease, Mol. Imaging Biol., 9, 204, 10.1007/s11307-007-0094-3 Edmondson, 2004, Structure and mechanism of monoamine oxidase, Curr. Med. Chem., 11, 1983, 10.2174/0929867043364784 Elmore, 2005, Final report of the safety assessment of l-ascorbic acid, calcium ascorbate, magnesium ascorbate, magnesium ascorbyl phosphate, sodium ascorbate, and sodium ascorbyl phosphate as used in cosmetics, Int. J. Toxicol., 24, 51 Fawdry, 2007, Radiolysis of 2-[18F]fluoro-2-deoxy-d-glucose (FDG) and the role of reductant stabilizers, Appl. Radiat. Isot., 65, 1193, 10.1016/j.apradiso.2007.05.011 Fowler, J.S., Wolf, A.P., 1982. The synthesis of carbon-11, fluorine-18, and nitrogen-13 labeled radiotracers for biomedical applications. Technical Information Center, US Department of Energy, p. 124. Fukumura, 2003, Decomposition of an aqueous solution of [11C]Ro 15-4513: implication of hydrated electrons in the radiolysis of [11C]Ro 15-4513, Nucl. Med. Biol., 30, 389, 10.1016/S0969-8051(03)00018-0 Fukumura, 2004, Stability of 11C-labeled PET radiopharmaceuticals, Appl. Radiat. Isot., 61, 1279, 10.1016/j.apradiso.2004.04.011 Fukumura, 2004, Radiolysis of [11C]iomazenil solution, Radiochim. Acta., 92, 119, 10.1524/ract.92.2.119.27464 Green, 2003, Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059, Pharmacol. Ther., 100, 195, 10.1016/j.pharmthera.2003.07.003 Halliwell, 2005 Hlavica, 2002, N-oxidative transformation of free and N-substituted amine functions by cytochrome P450 as means of bioactivation and detoxication, Drug Metab. Rev., 34, 451, 10.1081/DMR-120005646 Kim, 2007, α-Phenyl-N-tert-butyl nitrone (PBN) derivatives: synthesis and protective action against microvascular damages induced by ischemia/reperfusion, Bioorg. Med. Chem., 15, 3572, 10.1016/j.bmc.2007.02.033 Klok, 2008, Synthesis of 2-(1,1-Dicyanopropen-2-yl)-6-(2-[18F]-fluoroethyl)-methylamino-naphthalene ([18F]FDDNP), Appl. Radiat. Isot., 66, 203, 10.1016/j.apradiso.2007.10.008 Kotake, 1999, Pharmacologic properties of phenyl N-tert-butyl nitrone, Antioxid. Redox Signal, 1, 481, 10.1089/ars.1999.1.4-481 Kudo, Y., Suzuki, M., Suemoto, T., Okamura, N., Shiomitsu, T., Shimazu, H., 2004. Quinoline derivative as diagnostic probe for disease with tau protein accumulation. PCT Int. Appl. WO2004054978, p. 47. La Ferla, 2007, Oddo Salvatore, Intracellular amyloid-beta in Alzheimer's disease, Nat. Rev. Neuroscience, 8, 499, 10.1038/nrn2168 Liu, 2003, Ascorbic acid: useful as a buffer agent and radiolytic stabilizer for metalloradiopharmaceuticals, Bioconjugate Chem., 14, 1052, 10.1021/bc034109i Liu, 2007, High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]Fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) ready for animal or human administration, Mol. Imaging Biol., 9, 6, 10.1007/s11307-006-0061-4 MacGregor, 1987, Fluorine-18-N-methylspiroperidol: radiolytic decomposition as a consequence of high specific activity and high dose levels, J. Nucl. Med., 28, 60 Mathis, 2007, Impact of amyloid imaging on drug development in Alzheimer's disease, Nucl. Med. Biol., 34, 809, 10.1016/j.nucmedbio.2007.06.015 Mock, 1997, A color spot test for the detection of Kryptofix 2.2.2 in [18F]FDG preparations, Nucl. Med. Biol., 24, 193, 10.1016/S0969-8051(96)00212-0 Nordberg, 2004, PET imaging of amyloid in Alzheimer's disease, Lancet Neurol., 3, 519, 10.1016/S1474-4422(04)00853-1 Okamura, 2005, Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease, J. Neurosci., 25, 10857, 10.1523/JNEUROSCI.1738-05.2005 Ono, 2003, 11C-labeled stilbene derivatives as Ab-aggregate-specific PET imaging agents for Alzheimer's disease, Nucl. Med. Biol., 30, 565, 10.1016/S0969-8051(03)00049-0 Pallas, 2006, Molecular and biochemical features in Alzheimer's disease, Curr. Pharm. Des., 12, 4389, 10.2174/138161206778792967 Reybier, 2006, Radical trapping properties of imidazolyl nitrones, Free Radical Res., 40, 11, 10.1080/10715760500329598 Scott, 2007, Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human use, Appl. Radiat. Isot., 65, 1359, 10.1016/j.apradiso.2007.04.020 Sheweita, 2000, Drug- metabolizing enzymes: mechanisms and functions, Curr. Drug Metab., 1, 107, 10.2174/1389200003339117 Skovronsky, 2008, Results of multi-center trials comparing four 18F PET amyloid-imaging agents: preclinical to clinical correlations, J. Nucl. Med., 49, 34 Small, 2006, PET of brain amyloid and tau in mild cognitive impairment, New Engl. J. Med., 355, 2652, 10.1056/NEJMoa054625 Suzuki, 1990, Production of 3-N-[11C]methylspiperone with high specific activity and high radiochemical purity for PET studies: suppression of its radiolysis, Appl. Radiat. Isot., 41, 593, 10.1016/0883-2889(90)90046-J Tipton, 2004, Monoamine oxidases: certainties and uncertainties, Curr. Med. Chem., 11, 1965, 10.2174/0929867043364810 Uehleke, 1973, Role of cytochrome P-450 in the N-oxidation of individual amines, Drug Metab. Dispos., 1, 299 Werner, 1990, The effectiveness of various scavengers on the γ-irradiated, methanolic solution of medazepam, Int. J. Pharm., 63, 155, 10.1016/0378-5173(90)90166-2 Zhang, 2007, 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging, Nucl. Med. Biol., 34, 89, 10.1016/j.nucmedbio.2006.10.003